These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3127863)

  • 41. Comparative studies of the binding of dimeric and monomeric enkephalins to neuroblastoma-glioma NG108-15 cells.
    Krumins SA; Rodbard D
    J Neurochem; 1985 Jul; 45(1):101-7. PubMed ID: 2987405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The entry of [D-penicillamine2,5]enkephalin into the central nervous system: saturation kinetics and specificity.
    Thomas SA; Abbruscato TJ; Hruby VJ; Davis TP
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1235-40. PubMed ID: 9067309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
    Cruciani RA; Lutz RA; Munson PJ; Rodbard D
    J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of cationic drug-sensitive transport systems at the blood-cerebrospinal fluid barrier in para-tyramine elimination from rat brain.
    Akanuma SI; Yamazaki Y; Kubo Y; Hosoya KI
    Fluids Barriers CNS; 2018 Jan; 15(1):1. PubMed ID: 29307307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic inactivation of Leu-enkephalin.
    MacKinnon KL; Zuzel KA; Billington D
    Regul Pept; 1996 Dec; 67(2):85-92. PubMed ID: 8958578
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of [D-Ala2,Met5]enkephalinamide and [D-Ala2,D-Leu5]enkephalin on cholinergic and noradrenergic neurotransmission in isolated atria.
    Wong-Dusting HK; Rand MJ
    Eur J Pharmacol; 1985 Apr; 111(1):65-72. PubMed ID: 2990945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
    Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic ethanol alters the receptor binding characteristics of the delta opioid receptor ligand, D-Ala2-D-Leu5 enkephalin in mouse brain.
    Hynes MD; Lochner MA; Bemis KG; Hymson DL
    Life Sci; 1983 Dec; 33(23):2331-7. PubMed ID: 6316062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Melphalan potently substitutes the N-terminal Tyr of D-Ala2-Leu5-enkephalin methyl ester.
    Szücs M; Di Gleria K; Medzihradszky K
    FEBS Lett; 1985 Jan; 179(1):87-90. PubMed ID: 2981183
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the interactions of mu and delta selective ligands with [3H]D-Ala2-D-Leu5-enkephalin binding to mouse brain membranes.
    Barrett RW; Vaught JL
    Life Sci; 1983 Dec; 33(24):2439-48. PubMed ID: 6316063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective inhibition of synaptosomal proline uptake by leucine and methionine enkephalins.
    Rhoads DE; Peterson NA; Raghupathy E
    J Biol Chem; 1983 Oct; 258(20):12233-7. PubMed ID: 6138350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolism of enkephalin in stomach wall of rats.
    Bunnett NW; Walsh JH; Debas HT
    Am J Physiol; 1990 Jan; 258(1 Pt 1):G143-51. PubMed ID: 2405705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opiate-like peptides. Part VIII. Methylamides and dimethylamides of [D-Leu5]-enkephalin and [D-Ala2, D-Leu5]-enkephalin. Synthesis and analgesic activity.
    Rolka K; Kolasa K; Kleinrok Z; Kupryszewski G
    Pol J Pharmacol Pharm; 1986; 38(4):391-402. PubMed ID: 3534824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Enkephalins and the function of the sympathetic-adrenal system in acute myocardial ischemia].
    Alekminskaia LA; Lishmanov IuB; Slepushkin VD; Titov MI
    Biull Eksp Biol Med; 1985 May; 99(5):535-7. PubMed ID: 4005404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new potential affinity label for the opiate receptor.
    Szücs M; Di Gleria K; Medzihradszky K
    Life Sci; 1983; 33 Suppl 1():435-8. PubMed ID: 6319899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of acid secretion from enriched guinea pig parietal cells by opioid receptors.
    Kromer W; Skowronek B; Stark H; Netz S
    Pharmacology; 1983; 27(5):298-304. PubMed ID: 6318233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. No inotropic action of enkephalins or enkephalin derivatives on electrically-stimulated atria isolated from lean and obese rats.
    Saunders WS; Thornhill JA
    Br J Pharmacol; 1985 Jun; 85(2):513-22. PubMed ID: 4027480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The nature of cation-binding groups in binding sites for [[3H]Tyr1, D-Ala2, D-Leu5]enkephalin].
    Zaĭtsev SV; Porodenko NV; Varfolomeev SD
    Bioorg Khim; 1985 Feb; 11(2):153-61. PubMed ID: 2986652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the binding characteristics of tritiated opiates and opioid peptides.
    Gillan MG; Kosterlitz HW; Paterson SJ
    Br J Pharmacol; 1980 Nov; 70(3):481-90. PubMed ID: 7437652
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Co-localization of hypocretin-1 and leucine-enkephalin in hypothalamic neurons projecting to the nucleus of the solitary tract and their effect on arterial pressure.
    Ciriello J; Caverson MM; McMurray JC; Bruckschwaiger EB
    Neuroscience; 2013 Oct; 250():599-613. PubMed ID: 23912034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.